| The design of leadlike combinatorial libraries SJ Teague, AM Davis, PD Leeson, T Oprea Angewandte Chemie International Edition 38 (24), 3743-3748, 1999 | 1150 | 1999 |
| Is there a difference between leads and drugs? A historical perspective TI Oprea, AM Davis, SJ Teague, PD Leeson Journal of chemical information and computer sciences 41 (5), 1308-1315, 2001 | 1090 | 2001 |
| A comparison of physiochemical property profiles of development and marketed oral drugs MC Wenlock, RP Austin, P Barton, AM Davis, PD Leeson Journal of medicinal chemistry 46 (7), 1250-1256, 2003 | 684 | 2003 |
| Application and limitations of X‐ray crystallographic data in structure‐based ligand and drug design AM Davis, SJ Teague, GJ Kleywegt Angewandte Chemie International Edition 42 (24), 2718-2736, 2003 | 583 | 2003 |
| Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis AM Davis, SJ Teague Angewandte Chemie International Edition 38 (6), 736-749, 1999 | 519 | 1999 |
| Time-related differences in the physical property profiles of oral drugs PD Leeson, AM Davis Journal of medicinal chemistry 47 (25), 6338-6348, 2004 | 392 | 2004 |
| An alternative method for the evaluation of docking performance: RSR vs RMSD D Yusuf, AM Davis, GJ Kleywegt, S Schmitt Journal of chemical information and modeling 48 (7), 1411-1422, 2008 | 351 | 2008 |
| Chemical predictive modelling to improve compound quality JG Cumming, AM Davis, S Muresan, M Haeberlein, H Chen Nature reviews Drug discovery 12 (12), 948-962, 2013 | 346 | 2013 |
| Cyber security in new space: Analysis of threats, key enabling technologies and challenges M Manulis, CP Bridges, R Harrison, V Sekar, A Davis International Journal of Information Security 20 (3), 287-311, 2021 | 238 | 2021 |
| Partitioning of ionizing molecules between aqueous buffers and phospholipid vesicles RP Austin, AM Davis, CN Manners Journal of pharmaceutical sciences 84 (10), 1180-1183, 1995 | 225 | 1995 |
| Limitations and lessons in the use of X-ray structural information in drug design AM Davis, SA St-Gallay, GJ Kleywegt Drug discovery today 13 (19-20), 831-841, 2008 | 213 | 2008 |
| Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks™ HT MH Bridgland-Taylor, AC Hargreaves, A Easter, A Orme, DC Henthorn, ... Journal of pharmacological and toxicological methods 54 (2), 189-199, 2006 | 179 | 2006 |
| Predictive ADMET studies, the challenges and the opportunities AM Davis, RJ Riley Current opinion in chemical biology 8 (4), 378-386, 2004 | 159 | 2004 |
| Components of successful lead generation AM Davis, DJ Keeling, J Steele, NP Tomkinson, AC Tinker Current Topics in Medicinal Chemistry 5 (4), 421-439, 2005 | 141 | 2005 |
| Charge description of base-catalyzed alcoholysis of aryl phosphodiesters: A ribonuclease model AM Davis, AD Hall, A Williams Journal of the American Chemical Society 110 (15), 5105-5108, 1988 | 120 | 1988 |
| A single transition state in the reaction of aryl diphenylphosphinate esters with phenolate ions in aqueous solution N Bourne, E Chrystiuk, AM Davis, A Williams Journal of the American Chemical Society 110 (6), 1890-1895, 1988 | 120 | 1988 |
| Cognitive aspects of recalling and reporting health-related events: Papanicolaou smears, clinical breast examinations, and mammograms RB Warnecke, S Sudman, TP Johnson, D O'Rourke, AM Davis, JB Jobe American Journal of Epidemiology 146 (11), 982-992, 1997 | 115 | 1997 |
| Drug-like properties: guiding principles for design–or chemical prejudice? PD Leeson, AM Davis, J Steele Drug Discovery Today: Technologies 1 (3), 189-195, 2004 | 111 | 2004 |
| In Silico Human and Rat Vss Quantitative Structure−Activity Relationship Models MP Gleeson, NJ Waters, SW Paine, AM Davis Journal of medicinal chemistry 49 (6), 1953-1963, 2006 | 108 | 2006 |
| Pharmacogenomics‐based point‐of‐care clinical decision support significantly alters drug prescribing PH O'Donnell, N Wadhwa, K Danahey, BA Borden, SM Lee, JP Hall, ... Clinical Pharmacology & Therapeutics 102 (5), 859-869, 2017 | 101 | 2017 |
